Pulsenmore

Pulsenmore Total Assets

The Total Assets of Pulsenmore (PLSM.TA) as of Nov 21, 2026 is 101.85 M ILS. In the previous year, Total Assets was 141.50 M ILS — a change of -28.03% (lower).

Total Assets

101.85 MILS

YoY

-28.03%

Last updated:

Total Assets of Pulsenmore is 2025 101.85 M ILS. Total Assets of Pulsenmore was 2024 141.50 M ILS. It decreases by -28.03% lower compared to the previous year.

The Pulsenmore Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2019
6.32 M ILS
Jan 1, 2020
9.01 M ILS
Jan 1, 2021
167.04 M ILS
Jan 1, 2022
231.45 M ILS
Jan 1, 2023
178.37 M ILS
Jan 1, 2024
141.50 M ILS
Jan 1, 2025
101.85 M ILS
The Pulsenmore Total Assets history
YEARTotal AssetsYoY
101.85 MILS-28.03%
141.50 MILS-20.67%
178.37 MILS-22.93%
231.45 MILS+38.56%
167.04 MILS+1,752.98%
9.01 MILS+42.55%
6.32 MILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulsenmore Stock analysis

What does Pulsenmore do? Pulsenmore Ltd. generates revenue through the sale of its two miniaturized ultrasound systems, PulseNmore ES and PulseNmore FC, designed for home use in remote clinical diagnosis. The PulseNmore ES targets pregnant women requiring regular ultrasound monitoring, while PulseNmore FC caters to women undergoing in vitro fertilization needing follicle size assessments. Both systems integrate with smartphones, enabling patients to conduct tests at home and share results online with healthcare providers. The company also monetizes through software delivery for its devices, enhancing user experience and data management. The primary buyers of PulseNmore ES are pregnant women seeking convenient, clinic-free monitoring, and healthcare providers managing prenatal care remotely. PulseNmore FC is purchased by women undergoing in vitro fertilization, often through fertility clinics or medical centers that recommend the device. These segments value the convenience of home-based diagnostics and seamless telehealth integration without requiring in-person visits. Pulsenmore Ltd. focuses on global markets for its portable ultrasound solutions, serving patients in remote or underserved areas who benefit from telehealth-enabled diagnostics. The company’s products are positioned as cost-effective alternatives to traditional clinic visits, appealing to both end-users and healthcare institutions aiming to reduce operational costs while maintaining patient care quality. Pulsenmore is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulsenmore stock

Total Assets of Pulsenmore is 101.85 M ILS in 2025.

Total Assets of Pulsenmore changed from 141.50 M ILS to 101.85 M ILS, representing a -28.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Pulsenmore since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Pulsenmore historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Pulsenmore

All Key Metrics — Pulsenmore